Uploaded November 2024 | Updated November 2026, 3 days ago
【The Shaw Prize in Life Science & Medicine 2024】
Sickle cell disease and β thalassemia are blood disorders that affect more than 20 million people worldwide. Five percent of the world’s population carry the trait genes for hemoglobin disorders and 300,000 babies are born each year with severe hemoglobin disorders. Most people who have sickle cell disease are of African ancestry or self-identify as Black. The sickle cell trait protects against malaria, explaining the prevalence of the sickle gene in populations in particular regions of the world.
The Shaw Prize in Life Science and Medicine 2024 is awarded in equal shares to Swee Lay Thein, Senior Investigator and Chief of the Sickle Cell Branch, National Heart, Lung, and Blood Institute at the National Institutes of Health, USA and Stuart Orkin, David G Nathan Distinguished Professor of Pediatrics at Harvard Medical School, USA, for their discovery of the genetic and molecular mechanisms underlying the fetal-to-adult hemoglobin switch, making possible a revolutionary and highly effective genome-editing therapy for sickle cell anemia and β thalassemia, devastating blood diseases that affect millions of people worldwide.
******
Chapters:
00:51 Swee Lay Thein (Shaw Laureates in Life Science & Medicine 2024)
11:30 Stuart Orkin (Shaw Laureates in Life Science & Medicine 2024)
******
#shawprize #shawprize2024 #shawprizelaureates2024 #lifescienceandmedicine #sicklecelldisease
@NIHgov @harvardmedicalschool
【The Shaw Prize in Life Science & Medicine 2024】
Sickle cell disease and β thalassemia are blood disorders that affect more than 20 million people worldwide. Five percent of the world’s population carry the trait genes for hemoglobin disorders and 300,000 babies are born each year with severe hemoglobin disorders. Most people who have sickle cell disease are of African ancestry or self-identify as Black. The sickle cell trait protects against malaria, explaining the prevalence of the sickle gene in populations in particular regions of the world.
The Shaw Prize in Life Science and Medicine 2024 is awarded in equal shares to Swee Lay Thein, Senior Investigator and Chief of the Sickle Cell Branch, National Heart, Lung, and Blood Institute at the National Institutes of Health, USA and Stuart Orkin, David G Nathan Distinguished Professor of Pediatrics at Harvard Medical School, USA, for their discovery of the genetic and molecular mechanisms underlying the fetal-to-adult hemoglobin switch, making possible a revolutionary and highly effective genome-editing therapy for sickle cell anemia and β thalassemia, devastating blood diseases that affect millions of people worldwide.
******
Chapters:
00:51 Swee Lay Thein (Shaw Laureates in Life Science & Medicine 2024)
11:30 Stuart Orkin (Shaw Laureates in Life Science & Medicine 2024)
******
#shawprize #shawprize2024 #shawprizelaureates2024 #lifescienceandmedicine #sicklecelldisease
@NIHgov @harvardmedicalschool










